Intrathecal Recombinant Human Hepatocyte Growth Factor for Acute Cervical Spinal Cord Injury with AIS Grade A at 72 h Post-Injury: Phase III Study of Safety and Efficacy
{{output}}
The acute management of traumatic spinal cord injury (SCI) continues to lack a universally accepted pharmacological intervention. We developed a novel therapeutic strategy, intrathecal administration of pharmaceutical recombinant human hepatocyte growth factor... ...
